低危甲状腺微小乳头状癌患者主动监测与即刻甲状腺叶切除术患者报告结局的比较:KoMPASS队列的初步发现
这项多中心前瞻性队列研究纳入927例低危甲状腺微小乳头状癌患者(主动监测组453例,甲状腺叶切除术组474例),比较两组临床特征和生活质量。年龄较大、肿瘤较小、甲状腺癌家族史、既往了解主动监测及收入较高与选择主动监测的可能性更高相关。主动监测组总体生活质量评分显著更优,但12个月后两组生活质量无显著差异。
要点
- 年龄较大、肿瘤较小、有甲状腺癌家族史、了解主动监测及收入较高与选择主动监测相关。
- 主动监测组总体生活质量评分显著优于甲状腺叶切除术组(β 0.17,CI 0.02-0.33,p=0.029)。
- 基线生活质量主动监测组显著更优(7.1±1.2 vs 6.7±1.2,p<0.001),但12个月后两组无显著差异(7.2±1.2 vs 7.1±1.2,p=0.592)。
核心结论
- 年龄、肿瘤大小、甲状腺癌家族史、对主动监测的了解和收入与低危甲状腺微小乳头状癌患者的治疗选择相关。
- 主动监测组总体生活质量评分显著更高,但12个月后两组生活质量变得相似。
研究设计与样本
- 多中心前瞻性队列研究,比较主动监测与甲状腺叶切除术,共纳入927例低危甲状腺微小乳头状癌患者(主动监测组453例,甲状腺叶切除术组474例)。
- 生活质量问卷在初始年份每6个月施测一次,此后每年施测一次。
主要发现
- 平均年龄47.4±12.2岁,女性占72.2%。
- 年龄较大(OR 1.04,CI 1.02-1.05,p<0.001)、肿瘤较小(OR 0.78,CI 0.69-0.87,p<0.001)、甲状腺癌家族史(OR 1.48,CI 1.03-2.12,p=0.035)、既往了解主动监测(OR 1.53,CI 1.16-2.02,p=0.003)及收入较高(OR 1.79,CI 1.13-2.83,p=0.013)与选择主动监测的可能性更高显著相关。
- 主动监测组中位随访27.3个月(23.9-43.9),甲状腺叶切除术组中位随访28.7个月(20.4-44.5)。
- 随访期间主动监测组生活质量评分显著优于甲状腺叶切除术组(β 0.17,CI 0.02-0.33,p=0.029)。
- 基线生活质量评分主动监测组显著更优(7.1±1.2 vs 6.7±1.2,p<0.001),但12个月后两组无显著差异(7.2±1.2 vs 7.1±1.2,p=0.592)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Patients diagnosed with low-risk papillary thyroid microcarcinoma (PTMC) face the decision between thyroid lobectomy and active surveillance (AS). This study aimed to investigate the factors influencing treatment decisions in low-risk PTMC and to compare the quality of life (QoL) according to the treatment plan. Methods: The multicenter prospective cohort study comparing AS and thyroid lobectomy was conducted. Clinical characteristics were compared between the AS and Lobectomy groups. QoL questionnaires were administered every 6 months in the initial year and annually thereafter. Results: A total of 927 patients (453 in the AS group and 474 in the Lobectomy group) with low-risk PTMC were included in this study. The mean age was 47.4 ± 12.2 years, and 72.2% of the patients were women. Older age (odd ratio [OR] 1.04, confidence interval [CI] 1.02-1.05, p < 0.001), smaller tumor size (OR 0.78, CI 0.69-0.87, p < 0.001), family history of thyroid cancer (OR 1.48, CI 1.03-2.12, p = 0.035), prior awareness of AS (OR 1.53, CI 1.16-2.02, p = 0.003), and higher income (OR 1.79, CI 1.13-2.83, p = 0.013) were significantly associated with a higher likelihood of choosing AS. The median follow-up was 27.3 months (23.9-43.9) in the AS group and 28.7 months (20.4-44.5) in the Lobectomy group. During the follow-up period, the AS group showed significantly better QoL scores compared with the Lobectomy group (β 0.17, CI 0.02-0.33, p = 0.029). Although baseline QoL scores favored the AS group significantly (7.1 ± 1.2 vs. 6.7 ± 1.2, p < 0.001), no significant difference was observed after 12 months (7.2 ± 1.2 vs. 7.1 ± 1.2, p = 0.592). Conclusions: This study demonstrated that age, tumor size, family history of thyroid cancer, awareness of AS, and income were associated with patients' treatment choices. Although the overall QoL scores were significantly higher in the AS group, the QoL became similar between the two groups after 12 months. Clinical Trial Registration: KCT0004935.
引用
- Kim MJ, Won H, Kim WB, et al. Comparison of Patient-Reported Outcomes Between Active Surveillance and Immediate Lobectomy in Patients with Low-Risk Papillary Thyroid Microcarcinoma: Initial Findings from the KoMPASS Cohort. Thyroid. 2024. PMID: 39287055. doi:10.1089/thy.2024.0264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。